{"id":"NCT01817790","sponsor":"GlaxoSmithKline","briefTitle":"Assessment of Fluticasone Propionate on Ocular Allergy Symptoms","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy of Once-Daily Fluticasone Propionate Aqueous Nasal Spray 200mcg for 14 Days on Ocular Symptoms Associated With Seasonal Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2013-02","completion":"2013-02","firstPosted":"2013-03-25","resultsPosted":"2014-04-03","lastUpdate":"2014-04-03"},"enrollment":626,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":null},"conditions":["Allergic Rhinitis","Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Fluticasone propionate","otherNames":["Flonase"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Fluticasone propionate nasal spray","type":"EXPERIMENTAL"},{"label":"Placebo nasal spray","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to investigate the efficacy of fluticasone propionate (FP) on ocular symptoms associated with allergic rhinitis (AR).","primaryOutcome":{"measure":"Mean Change From Baseline in Reflective Total Ocular Symptom Score (rTOSS)","timeFrame":"Baseline to 14 days","effectByArm":[{"arm":"Fluticasone Propionate Nasal Spray","deltaMin":-0.91,"sd":1.625},{"arm":"Placebo Nasal Spray","deltaMin":-0.63,"sd":1.525}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0024"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["25624132"],"seeAlso":["http://www.ncbi.nlm.nih.gov/pubmed/14619333"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":314},"commonTop":["Pyrexia","Bronchitis","Headache","Pain","Thirst"]}}